These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2710236)

  • 61. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 62. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 63. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 64. [Acetylsalicylic acid after myocardial infarct].
    Sinzinger H; Kritz H
    Wien Klin Wochenschr; 1997; 109 Suppl 2():25-8. PubMed ID: 9340919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
    Lassila R
    Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
    [No Abstract]   [Full Text] [Related]  

  • 67. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV; Shalaev SV
    Ter Arkh; 2008; 80(12):89-95. PubMed ID: 19227916
    [No Abstract]   [Full Text] [Related]  

  • 68. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Brain attack. Acute therapeutic intervention. Antithrombotic and antiplatelet-aggregating drugs.
    Adams HP; Leira EC
    Neurosurg Clin N Am; 1997 Apr; 8(2):207-17. PubMed ID: 9113702
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Anticoagulants and platelet antiaggregants: lessons of the last 20 years].
    De Moerloose P; Boehlen F
    Rev Med Suisse Romande; 1998 Jul; 118(7):641-4. PubMed ID: 9708021
    [No Abstract]   [Full Text] [Related]  

  • 71. The approach to optimizing stroke care.
    Panagos PD
    Am J Emerg Med; 2008 Sep; 26(7):808-16. PubMed ID: 18774049
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The genetics of aspirin resistance.
    Goodman T; Sharma P; Ferro A
    Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unstable angina.
    Natarajan M
    Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
    [No Abstract]   [Full Text] [Related]  

  • 75. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].
    Codinach Huix P
    Med Clin (Barc); 1996 Apr; 106(15):586-9. PubMed ID: 8656759
    [No Abstract]   [Full Text] [Related]  

  • 76. [Antithrombotic therapy after peripheral arterial revascularization].
    Gäbel G; Bergert H; Weiss N
    MMW Fortschr Med; 2016 Aug; 158(14):52-5. PubMed ID: 27525786
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.